460 related articles for article (PubMed ID: 17300813)
1. Establishment of an allergic rhinitis model in mice for the evaluation of nasal symptoms.
Tsunematsu M; Yamaji T; Kozutsumi D; Murakami R; Kimura S; Kino K
Life Sci; 2007 Mar; 80(15):1388-94. PubMed ID: 17300813
[TBL] [Abstract][Full Text] [Related]
2. Absence of nasal blockage in a Japanese cedar pollen-induced allergic rhinitis model mouse.
Ogita-Nakanishi H; Nabe T; Mizutani N; Fujii M; Kohno S
Allergol Int; 2009 Jun; 58(2):171-8. PubMed ID: 19240378
[TBL] [Abstract][Full Text] [Related]
3. Effect of Cry-consensus peptide, a novel recombinant peptide for immunotherapy of Japanese cedar pollinosis, on an experimental allergic rhinitis model in B10.S mice.
Tsunematsu M; Yamaji T; Kozutsumi D; Murakami R; Kimura S; Kino K
Allergol Int; 2007 Dec; 56(4):465-72. PubMed ID: 17965586
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of a T cell epitope inhibits symptoms and reactions of allergic rhinitis in Japanese cedar pollen allergen-sensitized mice.
Murasugi T; Nakagami Y; Yoshitomi T; Hirahara K; Yamashita M; Taniguchi Y; Sakaguchi M; Ito K
Eur J Pharmacol; 2005 Mar; 510(1-2):143-8. PubMed ID: 15740735
[TBL] [Abstract][Full Text] [Related]
5. A new murine model of allergic rhinitis by repeated intranasal Cry j 1 challenge.
Tsunematsu M; Yamaji T; Kozutsumi D; Murakami R; Nagai H; Kino K
Biomed Res; 2008 Jun; 29(3):119-23. PubMed ID: 18614844
[TBL] [Abstract][Full Text] [Related]
6. Peptide immunotherapy for allergic diseases using a rice-based edible vaccine.
Hiroi T; Takaiwa F
Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):455-60. PubMed ID: 17088651
[TBL] [Abstract][Full Text] [Related]
7. Anti-allergic potential of oligomannose-coated liposome-entrapped Cry j 1 as immunotherapy for Japanese cedar pollinosis in mice.
Ishii M; Koyama A; Iseki H; Narumi H; Yokoyama N; Kojima N
Int Immunopharmacol; 2010 Sep; 10(9):1041-6. PubMed ID: 20584630
[TBL] [Abstract][Full Text] [Related]
8. Effect of Ganoderma lucidum on pollen-induced biphasic nasal blockage in a guinea pig model of allergic rhinitis.
Mizutani N; Nabe T; Shimazu M; Yoshino S; Kohno S
Phytother Res; 2012 Mar; 26(3):325-32. PubMed ID: 21698671
[TBL] [Abstract][Full Text] [Related]
9. Identification of human T cell epitopes in Japanese cypress pollen allergen, Cha o 1, elucidates the intrinsic mechanism of cross-allergenicity between Cha o 1 and Cry j 1, the major allergen of Japanese cedar pollen, at the T cell level.
Sone T; Dairiki K; Morikubo K; Shimizu K; Tsunoo H; Mori T; Kino K
Clin Exp Allergy; 2005 May; 35(5):664-71. PubMed ID: 15898991
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of nasal barrier dysfunction at acute- and late-phase reactions in a guinea pig model of allergic rhinitis.
Elovsson S; Smailagic A; Erjefalt I; Zackrisson C; Eriksson C; Wang X
Vascul Pharmacol; 2005 Oct; 43(4):267-76. PubMed ID: 16257271
[TBL] [Abstract][Full Text] [Related]
11. DNA vaccination against Japanese cedar pollinosis in dogs suppresses type I hypersensitivity by controlling lesional mast cells.
Masuda K
Vet Immunol Immunopathol; 2005 Oct; 108(1-2):185-7. PubMed ID: 16098609
[TBL] [Abstract][Full Text] [Related]
12. IL-16 variability and modulation by antiallergic drugs in a murine experimental allergic rhinitis model.
Akiyama K; Karaki M; Kobayshi R; Dobashi H; Ishida T; Mori N
Int Arch Allergy Immunol; 2009; 149(4):315-22. PubMed ID: 19295235
[TBL] [Abstract][Full Text] [Related]
13. T cell epitopes in Japanese cedar (Cryptomeria japonica) pollen allergens: choice of major T cell epitopes in Cry j 1 and Cry j 2 toward design of the peptide-based immunotherapeutics for the management of Japanese cedar pollinosis.
Sone T; Morikubo K; Miyahara M; Komiyama N; Shimizu K; Tsunoo H; Kino K
J Immunol; 1998 Jul; 161(1):448-57. PubMed ID: 9647255
[TBL] [Abstract][Full Text] [Related]
14. Effect of 5-aminosalicylate on allergic rhinitis model in mice.
Kuyama S; Yamamoto A; Sugiyama M; Kakuta H; Sugimoto Y
Int Immunopharmacol; 2010 Jun; 10(6):713-6. PubMed ID: 20304104
[TBL] [Abstract][Full Text] [Related]
15. Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosis.
Wakasa Y; Takagi H; Hirose S; Yang L; Saeki M; Nishimura T; Kaminuma O; Hiroi T; Takaiwa F
Plant Biotechnol J; 2013 Jan; 11(1):66-76. PubMed ID: 23066780
[TBL] [Abstract][Full Text] [Related]
16. Asian sand dust aggravates allergic rhinitis in guinea pigs induced by Japanese cedar pollen.
Ichinose T; Hiyoshi K; Yoshida S; Takano H; Inoue K; Nishikawa M; Mori I; Kawazato H; Yasuda A; Shibamoto T
Inhal Toxicol; 2009 Oct; 21(12):985-93. PubMed ID: 19552583
[TBL] [Abstract][Full Text] [Related]
17. Intranasal application of Epstein-Barr virus/lipoplex to abrogate eosinophillia in murine model of allergic rhinitis.
Han DM; Zhou B; Wang T; Wang XD; Fan EZ
Chin Med J (Engl); 2006 Jun; 119(12):991-7. PubMed ID: 16805982
[TBL] [Abstract][Full Text] [Related]
18. Effects of cryptoporus polysaccharide on rat allergic rhinitis associated with inhibiting eotaxin mRNA expression.
Xie QM; Deng JF; Deng YM; Shao CS; Zhang H; Ke CK
J Ethnopharmacol; 2006 Oct; 107(3):424-30. PubMed ID: 16765544
[TBL] [Abstract][Full Text] [Related]
19. IL-15 prevents allergic rhinitis through reactivation of antigen-specific CD8+ cells.
Aoi N; Masuda T; Murakami D; Yajima T; Mizubuchi H; Yamada H; Kawauchi H; Yoshikai Y
J Allergy Clin Immunol; 2006 Jun; 117(6):1359-66. PubMed ID: 16750998
[TBL] [Abstract][Full Text] [Related]
20. Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis.
Won TB; Quan SH; Kim DY; Rhee CS; Lee CH
Ann Allergy Asthma Immunol; 2009 Apr; 102(4):314-22. PubMed ID: 19441603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
